Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Benger Laboratories was a pioneering British pharmaceutical company based in Holmes Chapel, Cheshire, specializing in hematology and respiratory medicine. The company is most famous for developing Imferon (iron dextran), the first safe and effective intramuscular iron injection for treating iron deficiency anemia. It also played a critical role in the discovery of sodium cromoglicate (Intal), a breakthrough mast cell stabilizer that revolutionized the treatment of asthma. Originally established as Benger's Food Ltd, the firm was acquired by Fisons in 1947 and later became part of the Sanofi group. The research conducted at Benger Laboratories, particularly by scientist Roger Altounyan, remains a landmark in the history of inhalation therapy. Today, the company's former site continues to serve as a major manufacturing hub for global pharmaceutical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Benger Laboratories.